Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons

British Journal of Pharmacology

Volumn 170, Issue 1, 2013, Pages 222-232

  May, A C ^a   Fleischer, W ^a   Kletke, O ^a   Haas, H L ^a   Sergeeva, O A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

GABA; histamine; microelectrode array; single cell RT PCR; whole cell patch clamp; zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 ETHYL 6,7 DIMETHOXY BETA CARBOLINE 3 CARBOXYLIC ACID METHYL ESTER; CHLORDIAZEPOXIDE; DIAZEPAM; FLUMAZENIL; MIDAZOLAM; ZOLPIDEM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFICACY; DRUG POTENCY; EVOKED CORTICAL RESPONSE; HISTAMINERGIC NEURON; MALE; MOUSE; NERVE CELL; NEUROMODULATION; NEUROPHARMACOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBEROMAMMILLARY NUCLEUS;

GABA; HISTAMINE; MICROELECTRODE ARRAY; SINGLE-CELL RT-PCR; WHOLE-CELL PATCH-CLAMP; ZOLPIDEM;

ANIMALS; BENZODIAZEPINES; BINDING SITES; GABA MODULATORS; GENE KNOCKDOWN TECHNIQUES; HISTAMINE; HYPNOTICS AND SEDATIVES; HYPOTHALAMUS, POSTERIOR; MALE; MICE; MICE, MUTANT STRAINS; NEURONS; PROTEIN SUBUNITS; RECEPTORS, GABA-A; RNA, SMALL INTERFERING;

EID: 84881650157     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12280     Document Type: Article

References (57)

1. Agosto J, Choi JC, Parisky KM, Stilwell G, Rosbash M, Griffith LC, (2008). Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila. Nat Neurosci 11: 354-359.
2. Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, et al. (2009). Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 29: 14423-14438.
3. Anaclet C, Zhang M, Zhao C, Buda C, Seugnet L, Lin JS, (2012). Effects of GF-015535-00, a novel alpha1 GABA A receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem. Sleep 35: 103-111.
4. Assy N, Rosser BG, Grahame GR, Minuk GY, (1999). Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc 49: 690-694.
5. Baumann SW, Baur R, Sigel E, (2002). Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement. J Biol Chem 277: 46020-46025.
6. Buhr A, Baur R, Malherbe P, Sigel E, (1996). Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site. Mol Pharmacol 49: 1080-1084.
7. Buhr A, Baur R, Sigel E, (1997). Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site. J Biol Chem 272: 11799-11804.
8. Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, Ferraguti F, et al. (2004). Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit. Neuropharmacology 47: 17-34.
9. Crestani F, Assandri R, Tauber M, Martin JR, Rudolph U, (2002). Contribution of the alpha1-GABA(A) receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists. Neuropharmacology 43: 679-684.
10. Draguhn A, Verdorn TA, Ewert M, Seeburg PH, Sakmann B, (1990). Functional and molecular distinction between recombinant rat GABAA receptor subtypes by Zn2+. Neuron 5: 781-788.
11. Dursun M, Caliskan M, Canoruc F, Aluclu U, Canoruc N, Tuzcu A, et al. (2003). The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study. Swiss Med Wkly 133: 118-123.
12. Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B, (1998). Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1: 563-571.
13. Farrant M, Nusser Z, (2005). Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6: 215-229.
14. Gunther U, Benson J, Benke D, Fritschy JM, Reyes G, Knoflach F, et al. (1995). Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 92: 7749-7753.
15. Haas H, Panula P, (2003). The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4: 121-130.
16. Haas HL, Sergeeva OA, Selbach O, (2008). Histamine in the nervous system. Physiol Rev 88: 1183-1241.
17. Haq MM, Faisal N, Khalil A, Haqqi SA, Shaikh H, Arain N, (2012). Midazolam for sedation during diagnostic or therapeutic upper gastrointestinal endoscopy in cirrhotic patients. Eur J Gastroenterol Hepatol 24: 1214-1218.
18. Herb A, Wisden W, Luddens H, Puia G, Vicini S, Seeburg PH, (1992). The third gamma subunit of the gamma-aminobutyric acid type A receptor family. Proc Natl Acad Sci U S A 89: 1433-1437.
19. Itier V, Depoortere H, Scatton B, Avenet P, (1996). Zolpidem functionally discriminates subtypes of native GABAA receptors in acutely dissociated rat striatal and cerebellar neurons. Neuropharmacology 35: 137-145.
20. Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S, (2006). Pharmacological properties of GABAA receptors containing gamma1 subunits. Mol Pharmacol 69: 640-649.
21. Kletke O, Gisselmann G, May A, Hatt H, Sergeeva OA, (2013). Partial agonism of taurine at gamma-containing native and recombinant GABAA receptors. PLoS ONE 8: e61733.
22. Laccetti M, Manes G, Uomo G, Lioniello M, Rabitti PG, Balzano A, (2000). Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study. Dig Liver Dis 32: 335-338.
23. Laurie DJ, Wisden W, Seeburg PH, (1992). The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12: 4151-4172.
24. Leppa E, Linden AM, Rabe H, Vekovischeva OY, Wulff P, Luddens H, et al. (2011). Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-gamma2-dependent modulation. Eur J Pharmacol 666: 111-121.
25. Lorez M, Benke D, Luscher B, Mohler H, Benson JA, (2000). Single-channel properties of neuronal GABAA receptors from mice lacking the 2 subunit. J Physiol 527 (Pt 1): 11-31.
26. Malherbe P, Draguhn A, Multhaup G, Beyreuther K, Mohler H, (1990). GABAA-receptor expressed from rat brain alpha- and beta-subunit cDNAs displays potentiation by benzodiazepine receptor ligands. Brain Res Mol Brain Res 8: 199-208.
27. Mauric V, Molders A, Harmel N, Heimrich B, Sergeeva OA, Klocker N, (2013). Ontogeny repeats the phylogenetic recruitment of the cargo exporter cornichon into AMPA receptor signaling complexes. Mol Cell Neurosci 56C: 10-17.
28. Ogris W, Poltl A, Hauer B, Ernst M, Oberto A, Wulff P, et al. (2004). Affinity of various benzodiazepine site ligands in mice with a point mutation in the GABA(A) receptor gamma2 subunit. Biochem Pharmacol 68: 1621-1629.
29. Parisky KM, Agosto J, Pulver SR, Shang Y, Kuklin E, Hodge JJ, et al. (2008). PDF cells are a GABA-responsive wake-promoting component of the Drosophila sleep circuit. Neuron 60: 672-682.
30. Parmentier R, Ohtsu H, Djebbara-Hannas Z, Valatx JL, Watanabe T, Lin JS, (2002). Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 22: 7695-7711.
31. Parmentier R, Kolbaev S, Klyuch BP, Vandael D, Lin JS, Selbach O, et al. (2009). Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone. J Neurosci 29: 4471-4483.
32. Perkins KL, (2006). Cell-attached voltage-clamp and current-clamp recording and stimulation techniques in brain slices. J Neurosci Methods 154: 1-18.
33. Puia G, Vicini S, Seeburg PH, Costa E, (1991). Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol Pharmacol 39: 691-696.
34. Ramerstorfer J, Furtmuller R, Vogel E, Huck S, Sieghart W, (2010). The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes. Eur J Pharmacol 636: 18-27.
35. Rudolph U, Mohler H, (2006). GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 6: 18-23.
36. Saper CB, Scammell TE, Lu J, (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature 437: 1257-1263.
37. Sergeeva OA, (2013). GABAergic transmission in hepatic encephalopathy. Arch Biochem Biophys doi: 10.1016/j.abb.2013.04.005.
38. Sergeeva OA, Eriksson KS, Sharonova IN, Vorobjev VS, Haas HL, (2002). GABA(A) receptor heterogeneity in histaminergic neurons. Eur J Neurosci 16: 1472-1482.
39. Sergeeva OA, Andreeva N, Garret M, Scherer A, Haas HL, (2005). Pharmacological properties of GABAA receptors in rat hypothalamic neurons expressing the epsilon-subunit. J Neurosci 25: 88-95.
40. Sergeeva OA, Kletke O, Kragler A, Poppek A, Fleischer W, Schubring SR, et al. (2010). Fragrant dioxane derivatives identify beta1-subunit-containing GABAA receptors. J Biol Chem 285: 23985-23993.
41. Sherin JE, Elmquist JK, Torrealba F, Saper CB, (1998). Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 18: 4705-4721.
42. Sigel E, (2002). Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2: 833-839.
43. Stevenson A, Wingrove PB, Whiting PJ, Wafford KA, (1995). beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site. Mol Pharmacol 48: 965-969.
44. Thompson SA, Wingrove PB, Connelly L, Whiting PJ, Wafford KA, (2002). Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors. Mol Pharmacol 61: 861-869.
45. Vorobjev VS, Sharonova IN, Haas HL, (1996). A simple perfusion system for patch-clamp studies. J Neurosci Methods 68: 303-307.
46. Wafford KA, Ebert B, (2008). Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat Rev Drug Discov 7: 530-540.
47. Wafford KA, Bain CJ, Whiting PJ, Kemp JA, (1993). Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors. Mol Pharmacol 44: 437-442.
48. Walters RJ, Hadley SH, Morris KD, Amin J, (2000). Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nat Neurosci 3: 1274-1281.
49. Wingrove PB, Thompson SA, Wafford KA, Whiting PJ, (1997). Key amino acids in the gamma subunit of the gamma-aminobutyric acidA receptor that determine ligand binding and modulation at the benzodiazepine site. Mol Pharmacol 52: 874-881.
50. Wisden W, Laurie DJ, Monyer H, Seeburg PH, (1992). The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12: 1040-1062.
51. Wulff P, Goetz T, Leppa E, Linden AM, Renzi M, Swinny JD, et al. (2007). From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors. Nat Neurosci 10: 923-929.
52. Wulff P, Ponomarenko AA, Bartos M, Korotkova TM, Fuchs EC, Bahner F, et al. (2009). Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons. Proc Natl Acad Sci U S A 106: 3561-3566.
53. Yanovsky Y, Schubring S, Fleischer W, Gisselmann G, Zhu XR, Lubbert H, et al. (2012a). GABAA receptors involved in sleep and anaesthesia: beta1- versus beta3-containing assemblies. Pflugers Arch 463: 187-199.
54. Yanovsky Y, Schubring SR, Yao Q, Zhao Y, Li S, May A, et al. (2012b). Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block. PLoS ONE 7: e42512.
55. Yanovsky Y, Zigman JM, Kernder A, Bein A, Sakata I, Osborne-Lawrence S, et al. (2012c). Proton- and ammonium-sensing by histaminergic neurons controlling wakefulness. Front Syst Neurosci 6: 23.
56. Zecharia AY, Yu X, Gotz T, Ye Z, Carr DR, Wulff P, et al. (2012). GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J Neurosci 19: 13062-13075.
57. Zimmerman JE, Naidoo N, Raizen DM, Pack AI, (2008). Conservation of sleep: insights from non-mammalian model systems. Trends Neurosci 31: 371-376.